China-Focused Life Science Investor Acquires 37% of NovaBay for $28M
After the transaction, it will be NovaBay’s largest shareholder with 6.6 million shares, 37% of the total.
Source: BioSpace
After the transaction, it will be NovaBay’s largest shareholder with 6.6 million shares, 37% of the total.
Source: BioSpace